| Cash Flow | 2025-07-27 | 2025-04-27 | 2024-10-27 | 2024-07-28 |
|---|---|---|---|---|
| Write-off of deferred financing costs | 516 | 152 | 5,497 | 5,497 |
| Share-based compensation | 24,132 | 6,835 | 50,777 | 32,372 |
| Net loss | -7,719 | 19,345 | -201,040 | -193,454 |
| Amortization of right-of-use assets | 2,702 | 1,346 | 4,542 | 3,189 |
| Corporate-owned life insurance, net | -1,389 | -655 | -2,722 | -1,670 |
| Other assets | 2,770 | -2,281 | -597 | -3,705 |
| Other liabilities | -3,603 | -266 | -5,580 | -3,990 |
| Inventories | 19,628 | 6,627 | 18,446 | 11,031 |
| Deferred income taxes | -4,848 | -2,411 | 944 | 934 |
| Accrued liabilities | -11,440 | -15,444 | -8,813 | -26,660 |
| Accounts payable | 11,225 | 9,805 | 18,911 | 31,084 |
| Accounts receivable, net | -9,218 | 3,107 | 8,142 | 18,701 |
| Equity method income | 984 | 1,046 | 38 | 50 |
| Goodwill impairment | 41,991 | - | 0 | 0 |
| Loss on extinguishment of debt | 0 | - | -143,467 | -143,467 |
| Gain from sale of investments | 0 | 0 | 277 | 277 |
| Interest rate swap termination | 729 | -14 | - | - |
| Depreciation and amortization | 20,504 | 10,190 | 33,211 | 23,071 |
| Accretion of deferred financing costs | 2,525 | 1,254 | 6,814 | 4,758 |
| Investment impairments and credit loss reserves, net | 0 | 0 | 1,109 | 1,109 |
| Loss on disposition of business operations and assets | -42 | -26 | -124 | -91 |
| Amortization of inventory step-up | - | - | 0 | 0 |
| Net cash provided by (used in) operating activities | 72,219 | 27,824 | 24,491 | -5,084 |
| Proceeds from sales of property, plant and equipment | 3 | - | 73 | 73 |
| Proceeds from sale of investments | 536 | 536 | 2,650 | 2,650 |
| Proceeds from corporate-owned life insurance | 0 | 0 | 4,802 | 4,802 |
| Purchase of property, plant and equipment | 4,534 | 1,650 | 5,228 | 4,745 |
| Premiums paid for corporate-owned life insurance | 3,428 | 3,428 | - | - |
| Purchase of investments | 0 | - | 434 | 434 |
| Purchase of intangibles | 2,779 | 529 | 5,948 | 5,018 |
| Net cash used in investing activities | -10,202 | -5,071 | -4,085 | -2,672 |
| Payments of term loans | 35,000 | 10,000 | 0 | 0 |
| Payments of revolving line of credit | - | - | 5,000 | - |
| Proceeds from exercise of stock options | 500 | 32 | 1,248 | 643 |
| Proceeds from revolving line of credit | - | - | 0 | 0 |
| Proceeds from convertible senior notes | - | - | 0 | - |
| Proceeds from interest rate swap termination | 237 | - | - | - |
| Distributions to noncontrolling interest | 0 | 0 | 184 | 184 |
| Payments for employee share-based compensation payroll taxes | 12,191 | 8,901 | 7,297 | 4,185 |
| Deferred financing costs | 564 | 492 | 824 | 824 |
| Net cash used in financing activities | -47,018 | -19,361 | -12,057 | -4,550 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1,818 | 1,339 | -430 | -351 |
| Net increase (decrease) in cash and cash equivalents | 16,817 | 4,731 | 7,919 | -12,657 |
SEMTECH CORP (SMTC)
SEMTECH CORP (SMTC)